KELOWNA, BRITISH COLUMBIA--(MARKET WIRE)--Sep 24, 2007 -- Sernova Corp. (CDNX:SVA.V - News) today announced that it has retained the services of Arent Fox LLP to represent Sernova in matters before the US Food and Drug Administration (FDA). Arent Fox partner, James Ravitz, has successfully guided novel cellular therapy products through the FDA regulatory process.
